Skip to main content
OpenTrials

Clinical trial condition

Untreated Adult Acute Myeloid Leukemia

Explore clinical trials studying Untreated Adult Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

81 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Untreated Adult Acute Myeloid Leukemia trial results

Completed

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

NCT01101880

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +27 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01349972

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +27 more
Locations
  • Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT01567059

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +8 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT00475150

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +17 more
Locations
  • Howard University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

NCT00313586

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +28 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Los Angeles Oncology Institute Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 234 locations
View Trial Details

Related conditions